secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001104659-26-013465
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora prices $3.0B senior notes offering across five tranches to repay OneOncology acquisition debt
--------------------------------------------------------------------------------

- $3.0B aggregate of senior notes in five tranches: 2029 (3.950%), 2030 (4.250%), 2033 (4.600%), 2036 (4.900%), 2056 (5.650%).
- Net proceeds (~$2.98B) to repay 364-Day Term Loan (used for OneOncology) and for general corporate purposes.
- Offering expected to close February 13, 2026; joint book-runners: Citigroup, J.P. Morgan, BofA, Wells Fargo.
- Offered under shelf registration filed Nov 26, 2024; underwriting agreement entered Feb 10, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000110465926013465/0001104659-26-013465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000110465926013465/tm265391d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-013465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer